GlioCART is a University of Basel spin-off focused on translating a dual-action CAR-T therapy for glioblastoma into clinical application by combining tumor targeting with immune microenvironment reprogramming. Our mission is to achieve durable clinical benefit for patients with glioblastoma.
Member of the Swiss Biotech Association
Member
GlioCART GmbH
GlioCART GmbH
Verified listing
-
Founded2025
-
Employees in Switzerland1-9
- Website
- Get directions
- Bookmark
- Share
- Report
- prev
- next